Immuneering IMRX
NASDAQ IMRX
$3.85 +0.20 (+5.48%)
At close: Nov 10, 2026 · 4:00 PM EST

Immuneering (IMRX) Other financing activities (as filed) (2022 - 2025)

Updated

Immuneering's Other financing activities (as filed) was -$587,355 in Q4 2025, compared with -$40,988 a year earlier.

Analysis

Immuneering (IMRX) Other financing activities (as filed) (2022 - 2025) Analysis & Trends

For FY2025, Other financing activities (as filed) at Immuneering came in at -$3.73 million.

  • In earlier years, Other financing activities (as filed) was -$40,988 in FY2024, -$203,768 in FY2023, -$281,375 in FY2022 and -$2.12 million in FY2021.
  • Quarterly Other financing activities (as filed) has moved between -$3.07 million (Q3 2025) and -$40,988 (Q4 2024) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Immuneering 246.36 Mn -378.47 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -587,355.00
Sep 30, 2025 -3.07 Mn
Dec 31, 2024 -40,988.00
Dec 31, 2022 -226,775.00
Sep 30, 2022 -54,600.00
API Access

Immuneering Other financing activities (as filed) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=IMRX&period=max&api_key=YOUR_API_KEY